Product Introduction:
Carryl MV 60 Mg Tablet is a combination of Gliclazide (60 mg), Metformin (500 mg), and Voglibose (0.2 mg). This medicine works through a triple mechanism: improving insulin secretion, reducing glucose production, and slowing carbohydrate absorption in the intestine.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Control of fasting and postprandial blood glucose
-
Prevention of diabetes-related complications
Benefits:
-
Triple-action control over blood sugar levels
-
Effective for patients not responding to monotherapy
-
Helps reduce risk of nerve, kidney, and eye damage due to diabetes
-
Supports better glycemic control
Composition:
-
Gliclazide 60 mg (Modified Release)
-
Metformin Hydrochloride 500 mg
-
Voglibose 0.2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea or vomiting
-
Abdominal pain or bloating
-
Diarrhea or flatulence
-
Headache or dizziness
Safety Advice:
-
Take with meals to minimize gastrointestinal side effects and risk of hypoglycemia
-
Regularly monitor blood glucose levels
-
Avoid alcohol while on this medication
-
Not suitable during pregnancy or breastfeeding without medical guidance
-
Consult doctor if you have liver, kidney, or heart conditions
-
Do not skip meals while using this medication
